Abstract
Endoscopic biopsies are being increasingly utilized to investigate cytokine profiles in normal and diseased intestine. To evaluate the adequacy of mucosal biopsies as a source of cytokine-specific mRNA, we measured their content of interleukin-1β (IL-1β) and interleukin-2 (IL-2) mRNA by reverse transcription-polymerase chain reaction and compared it to that of autologous lamina propria mononuclear cells in control and inflammatory bowel disease-involved specimens. High-quality total RNA was recovered more consistently from cell isolates than from biopsies. Interleukin-1β mRNA was reliably detected in both cell and biopsy samples, whereas IL-2 mRNA was measurable in all lamina propria cells but not always in biopsies. Compared to controls, levels of IL-1β were significantly elevated in Crohn's disease and ulcerative colitis cells and biopsies, and a weak but significant correlation existed between values derived from the two sources. In contrast, only ulcerative colitis cell isolates but not biopsies contained significantly reduced concentrations of IL-2 mRNA compared to those of control and Crohn's disease samples, and no correlation was found between cell and biopsy contents. Widely different levels of cytokine-specific mRNA were present in closely adjacent biopsies, particularly for IL-2. These results suggest that mucosal biopsies are suitable to assess some but not all cytokine-specific mRNA due to variation in RNA recovery, intrinsic level of cytokine gene expression, and substantial variability of cytokine transcripts.
Similar content being viewed by others
References
Fiocchi C: Pathophysiology: Facts, hopes and implications for treatment.In Inflammatory Bowel Disease: Pathophysiology as Basis of Treatment. J Scholmerich, W Kruis, H Goebell, W Hohenberger, V Gross (eds). Lancaster, Kluwer Academic, 1993, pp 257–279
Fiocchi C: Cytokines.In Inflammatory Bowel Disease. From Bench to Bedside. SR Targan, F Shanahan (eds). Baltimore, Williams & Wilkins, 1994, pp 106–122
Paul WE: Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell 57:521–524, 1989
Erlich HA, Gelfand DH, Saiki RK: Specific DNA amplification. Nature 331:461–462, 1988
Fiocchi C, Hilfiker ML, Youngman KR, Doerder NC, Finke JH: Interleukin 2 activity of human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 86:734–742, 1984
Lieberman BY, Fiocchi C, Youngman KR, Sapatnekar WK, Proffitt MR: Interferon γ production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci 33:1528–1536, 1988
Mullin GE, Lazenby AJ, Harris ML, Bayless TM, James SP: Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 102:1620–1627, 1992
Salomon P, Pizzimenti A, Panja A, Reisman A, Mayer L: The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium. Autoimmunity 9:141–149, 1991
MacDonald TT, Hutchings P, Choy M-Y, Murch S, Cooke A: Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 81:301–305, 1990
Breese E, Braegger CP, Corrigan CJ, Walker-Smith JA, MacDonald TT: Interleukin-2- and interferon-γ-secreting T cells in normal and diseased human intestinal mucosa. Immunology 78:127–131, 1993
Wang AM, Doyle MV, Mark DF: Quantification of mRNA by polymerase chain reaction. Proc Natl Acad Sci USA 86:9717–9721, 1989
Siebert PD, Larrick JW: Competitive PCR. Nature 359:557–558, 1992
Fiocchi C: Cytokines.In Inflammatory Bowel Disease. RP MacDermott, W Stenson (eds). New York, Elsevier, 1992, pp 137–162
Fiocchi C, Battisto JR, Farmer RG: Gut mucosal lymphocytes in inflammatory bowel disease. Isolation and preliminary functional characterization. Dig Dis Sci 24:705–717, 1979
Matsuura T, West GA, Youngman KR, Klein JS, Fiocchi C: Immune activation genes in inflammatory bowel disease. Gastroenterology 104:448–458, 1993
Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, Fiocchi C: Localization of intestinal interleukin 1 activity, protein and gene expression to lamina propria cells. Gastroenterology 104:749–758, 1993
Strober W, Ehrhardt RO: Chronic intestinal inflammation: An unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75:203–205, 1993
Kusugami K, Matsuura T, West GA, Youngman KR, Rachmilewitz D, Fiocchi C: Loss of interleukin-2-producing intestinal CD4+T cells in inflammatory bowel disease. Gastroenterology 101:1594–1605, 1991
Matsuura T, West GA, Klein JS, Ferraris L, Fiocchi C: Soluble interleukin 2, CD8 and CD4 receptors in inflammatory bowel disease. A comparative study of peripheral blood and intestinal mucosal levels. Gastroenterology 102:2006–2014, 1992
Mahida YR, Gallagher A, Kurlak L, Hawkey CJ: Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease. Clin Exp Immunol 82:75–80, 1990
Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 31:686–689, 1990
Brynskov J, Tvede N, Andersen CB, Vilien M: Increased concentrations of interleukin 1β, interleukin-2, and soluble interleukin-2 receptors in endoscopic mucosal biopsies specimens with active inflammatory bowel disease. Gut 33:55–58, 1992
Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB: Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 37:818–826, 1992
Isaacs KL, Sartor RB, Haskill S: Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103:1587–1595, 1992
Mullin GE, Vezza FR, Sampat A, Maycon Z, Katz R, Eisenstein E, Weissman G, McKinley M, Fisher SE: Abnormal IL-10 mRNA production in the intestinal mucosal lesions of inflammatory bowel disease. Gastroenterology 104:A751, 1993
Dinarello CA, Wolf SM: The role of interleukin-1 in disease. N Engl J Med 328:106–113, 1993
Smith KA: Interleukin-2: Inception, impact, and implications. Science 240:1169–1176, 1988
Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohn's disease. Gut 30:835–838, 1989
MacDermott RP, Franklin GO, Jenkins KM, Kodner IJ, Nash GS, Weinrieb IJ: Human intestinal mononuclear cells. I. Investigation of antibody-dependent, lectin-induced, and spontaneous cell-mediated cytotoxic capabilities. Gastroenterology 78:47–56, 1980
Selby WS, Janossy G, Bofill M, Jewell DP: Intestinal lymphocyte subpopulations in inflammatory bowel disease: An analysis by immunohistological and cell isolation techniques. Gut 25:32–40, 1984
James SP, Fiocchi C, Graeff AS, Strober W: Phenotypic analysis of lamina propria lymphocytes. Gastroenterology 91:1483–1489, 1986
Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME: Microscopic activity in ulcerative colitis: What does it mean? Gut 32:174–178, 1991
Radford-Smith G, McGowan I, Keshav S, Jewell DP: Investigation of cytokine mRNA production in the normal human intestinal mucosa. Gastroenterology 106:A757, 1994
Khoo UY, Hunter RL, Peakman M, Forgacs I, Bjarnson I, Macpherson AJS: The distribution of human intestinal lymphocytes changes with site and differs from the periphery. Gastroenterology 106:A711, 1994
Blumberg RS, Yockey C, Balk SP: Oligoclonal expansion of human intestinal αβ T lymphocytes in epithelium and lamina propria. Gastroenterology A102:597, 1992
Author information
Authors and Affiliations
Additional information
This work was supported by a grant (DK 30399) from the National Institutes of Health (NIDDK).
Rights and permissions
About this article
Cite this article
Fukushima, K., West, G. & Fiocchi, C. Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA. Digest Dis Sci 40, 1498–1505 (1995). https://doi.org/10.1007/BF02285198
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02285198